Infectious Disease Diagnostics Market to Witness Unprecedented Growth By 2026


Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases.

Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Request Sample of Report:

Increasing prevalence of various infectious diseases is expected to boost the infectious disease diagnostics market growth over the forecast period

Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016.

According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover, around 323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection.

The global infectious disease diagnostics market size was valued at US$ 15,112.2 million in 2017, and is expected to witness a robust CAGR of 6.1% over the forecast period (2018 – 2026).

Partnerships and collaborations by market players to develop novel diagnostic techniques is expected to boost growth of the infectious disease diagnostics market

Individual organizations, manufacturers, and research institutes are forming partnerships, and collaborations to advance research and development of diagnostic tests for infectious diseases. Moreover, funding by individual organizations to advance research is expected to boost the growth of the market over the forecast period. For instance, the University of Virginia’s Global Infectious Diseases Institute funded seven projects designed to tackle challenging problems in infectious diseases worldwide in July 2018. They have formed collaborative teams across diverse academic disciplines to control and treat Zika virus infections and to reduce tuberculosis rates among HIV-infected patients in Africa.

Key Players

Some of the major players operating in the global infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Trinity Biotech Plc., Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech, Co. Ltd., and Acon Laboratories, Inc.

Detailed Segmentation:

Global Infectious Disease Diagnostics Market, By Disease Type:

  • HIV

  • Hepatitis

  • Healthcare Associated Infections (HAIs)

  • Human Papillomavirus (HPV)

  • Tuberculosis (TB)

  • Influenza

  • Others

Global Infectious Disease Diagnostics Market, By Technology:

  • Immunodiagnostics

  • Polymerase Chain Reaction (PCR)

  • Next Generation Sequencing (NGS)

  • Others

Browse Full Report:

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,


Seattle, WA 98154

Tel: +1-206-701-6702